semaglutide deaths 2024 reduced the risk of clinically important kidney outcomes and death from cardiovascular (CV) causes in patients with type 2 diabetes (T2D) and CKD ca. #ERA24 🇸🇪 #Nephpearls https://www.nejm.org/doi/full/10.1056/NEJMoa2403347 On the Increase in Use

doi: 10.3390/biomedicines11051499

"People taking semaglutide for weight loss often notice dramatic reductions in hunger and food noise when they begin this treatment

The future of compounded GLP-1 delivery Some compounding pharmacies have begun offering pre-measured dose syringes where each syringe contains exactly one dose, eliminating the need for patients to draw from vials

The implementation questions and corresponding responses from the clinical experts consulted by CADTH are summarized in Table 7

Genetic factors Certain genetic variants affect GLP-1 receptor sensitivity

How Long After Semaglutide Injection Do Side Effects Start